Pain Management Therapeutics Market
- 2026 年市場規模
- USD 89.3 Bn
- 2033 年預估規模
- USD 132.7 Bn
- 年複合成長率 CAGR
- 8.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Pain Management Therapeutics Market, By Pain Type (Chronic, Acute),By Drug Class (NSAIDS, Anesthetics, Anticonvulsant, Anti-migraine Drugs, Antidepressant Drugs, Opioids, Non-narcotics, Analgesics), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Pain management is a broad branch of medical science that utilizes an interdisciplinary approach to easing the patient's suffering and enhancing the quality of life of patients with chronic pain. A common aim of pain management is reducing the use of narcotics or pain killers, relaxing the patients' lifestyle and providing education on stress and pain management. The use of pain management treatments in combination with a holistic approach to disease prevention and therapy is now recognized as an effective treatment approach for moderate to severe pain. Chronic pain can result from injury, disease or injury, or be the result of a disease such as cancer or Parkinson's disease.
Market Dynamics
R&D of new therapeutics is expected to propel growth of the global pain management therapeutics market over the forecast period. For instance, in August 2021, Flexion Therapeutics, Inc. expanded the placebo-controlled trial of FX301, a novel formulation of a locally administered NaV1.7 inhibitor (funapide) which aims to provide at least three to five days of post-operative pain relief while preserving motor function, in patients undergoing bunionectomy.
Moreover, increasing number of pain management clinics is also expected to aid in growth of the market. For instance, in August 2021, QC Kinetix, a regenerative medicine company that offers a non-surgical alternative to pain relief, started a new location Birmingham.
Key features of the study
• This report provides in-depth analysis of the global pain management therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pain management therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AcelRx Pharmaceuticals, Inc. Averitas Pharma, Inc., AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson & Johnson, Teva Pharmaceuticals, Abbott Laboratories, Allergan, Inc., Covidien plc, Durect Corporation, Eli Lilly and Company, Endo Health Solutions, Inc., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Merck & Co., Inc., Mundipharma International Ltd., and Novartis International AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management therapeutics market
Market Segmentation
• By Pain Type (Revenue, USD Bn, 2021-2033)
o Chronic
o Acute
• By Drug Class (Revenue, USD Bn, 2021-2033)
o NSAIDS
o Anesthetics
o Anticonvulsant
o Anti-migraine Drugs
o Antidepressant Drugs
o Opioids
o Non-narcotics
o Analgesics
• By Indication (Revenue, USD Bn, 2021-2033)
o Arthritic Pain
o Neuropathic Pain
o Cancer Pain
o Chronic Pain
o Post-operative Pain
o Migraine
o Fibromyalgia
o Bone Fracture
o Muscle Sprain/Strain
o Acute Appendicitis
o Others
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o AcelRx Pharmaceuticals, Inc.
o Averitas Pharma, Inc.
o AmerisourceBergen
o Cardinal Health
o McKesson Corporation
o Johnson & Johnson
o Teva Pharmaceuticals
o Abbott Laboratories
o Allergan, Inc.
o Covidien plc
o Durect Corporation
o Eli Lilly and Company
o Endo Health Solutions, Inc.
o Forest Laboratories, Inc.
o GlaxoSmithKline plc
o Hospira, Inc.
o Merck & Co., Inc.
o Mundipharma International Ltd.
o Novartis International AG.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Pain Type
Market Snippet, By Drug Class
Market Snippet, By Indication
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Key Highlights
o Product launch
o Regulatory Scenario
o PEST Analysis
o Mergers and Acquisitions
4. Global Pain Management Therapeutics Market, By Pain Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Chronic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Acute
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Pain Management Therapeutics Market, By Drug Class, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o NSAIDS
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Anesthetics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Anticonvulsant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Anti-migraine Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Antidepressant Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Non-narcotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Pain Management Therapeutics Market, By Indication, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Arthritic Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Neuropathic Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Cancer Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Chronic Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Post-operative Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Migraine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Fibromyalgia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Bone Fracture
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Muscle Sprain/Strain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Acute Appendicitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Pain Management Therapeutics Market, By Region, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Company Profiles
AcelRx Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Averitas Pharma, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AmerisourceBergen
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cardinal Health
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
McKesson Corporation
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Teva Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Allergan, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Covidien plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Durect Corporation
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Endo Health Solutions, Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Forest Laboratories, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GlaxoSmithKline plc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hospira, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck & Co., Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Mundipharma International Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis International AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們